Exhibit 99.1
[LOGO OF QT5]
5655 Lindero Canyon Rd., Suite #120 o Westlake Village, CA 91362 USA
- --------------------------------------------------------------------------------
Phone: 818-338-1500 o Fax: 818-338-1550 o www.qt5inc.com
April 13, 2004
FOR IMMEDIATE RELEASE
QT 5, Inc. Acquires Xact Aid Product Line
WESTLAKE VILLAGE, Calif., April 13, 2004 (PRIMEZONE) -- QT 5, Inc. (OTC BB:
QTFV.OB - News), manufacturer, distributor and marketers of biomedical products,
today announced that it recently acquired the brand and all of the assets
belonging to Xact Aid Inc.
The Xact Aid line of First-Aid-Kits contain a variety of innovative wound
specific First-Aid-Packs that surpass any other product currently in the
consumer first-aid category. Xact Aid products are unique "all you need in one
box" wound-specific treatment packs that address the most common minor injuries
such as cuts, scrapes, insect-bites, minor-burns, burns and sprains.
These wound specific First-Aid-Packs provide the consumer with enough materials
to clean, treat, dress, and maintain a specific type of minor injury. Unlike
traditional First-Aid kits, which are old fashioned and contain the bare minimum
needed to treat a wound, Xact Aid Packs provide the precise products needed to
manage and maintain the healing process in its entirety. The packs effectively
take the guesswork out of treating a minor injury and will allow the consumer to
effectively treat themselves with a product that is not only convenient but
reliable and necessary.
Each injury-specific pack is color-coded and clearly notes the contents and
benefits of the specific treatment on the package. The kits contain
easy-to-follow English and Spanish instructions that guide the consumer through
the wound-care procedure from beginning to end.
According to QT 5, Inc. President Steven H. Reder, "When our management team
became aware of Xact Aid's product line, we immediately recognized it as a
unique concept with strong mainstream potential. They have done an incredible
job in creating the Xact Aid product line, which comes to us ready to go to
market. The image is strong, the vendors are in place and we have already begun
channel communications announcing the immediate availability of the entire
product line."
Mark Levine, founder of Xact Aid, will provide his expertise on behalf of QT 5
by managing the product development, marketing and sales activities related to
the Xact Aid family of products. Mr. Levine noted, "QT 5 has proven their
ability to pioneer medical products and has many existing relationships in major
distribution channels. I'm proud to be working with such a competent team and
furthermore feel confident that joining QT5 will provide Xact Aid's line of
products with tremendous opportunity for rapid success."
Mr. Reder added, "Xact Aid is the right product at the right time for us. It
fits into our product mix and business plan while providing us with an immediate
opportunity to build an additional revenue stream. We also continue to make
progress toward launching our Target System Diagnostic products and we have
recently launched an aggressive marketing campaign introducing our DRUG STOP
rapid urinalysis tests to the human resources and recruiting marketplace."
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer,
distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently
engaged in the development and introduction of Drug Stop rapid urinalysis tests
and Target System(tm) Diagnostic products as well as Xact Aid first-aid products
and continues to do research and development regarding future products for
lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village,
California. For more information on the Company please visit: www.qt5inc.com
This press release contains forward-looking statements that involve risks,
uncertainties and assumptions that, if they never materialize or prove
incorrect, could cause the results of QT 5, Inc. to differ materially from those
expressed or implied by such forward-looking statements. All statements other
than statements of historical fact are statements that could be deemed
forward-looking statements, including any projections of earnings, revenue, or
other financial items, any statements of the plans, strategies, and objectives
of management for future operations, any statements concerning proposed new
products, services or developments, any statements regarding future economic
conditions or performance, statements of belief and any statements of
assumptions underlying any of the foregoing. These statements are based on
expectations as of the date of this press release. Actual results may differ
materially from those projected because of a number of risks and uncertainties,
including those detailed from time to time in the reports filed by QT 5, Inc.
with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation
and does not intend to update these forward-looking statements.
# # #